MMP1 regulated by NEAT1/miR-361-5p axis facilitates the proliferation and migration of cutaneous squamous cell carcinoma via the activation of Wnt pathway

References

• Languino LR, Singh A, Prisco M, Inman GJ, Luginbuhl A, Curry JM, South AP. Exosome-mediated transfer from the tumor microenvironment increases TGFbeta signaling in squamous cell carcinoma. Am J Transl Res. 2016;8:2432–2437.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xiang P, Han X, Wu L, Li X, Xiong Z. Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8:11446–11451.
   PubMed Web of Science ®Google Scholar
• Zhou L, Wang Y, Ou C, Lin Z, Wang J, Liu H, Zhou M, Ding Z. microRNA-365-targeted nuclear factor I/B transcriptionally represses cyclin-dependent kinase 6 and 4 to inhibit the progression of cutaneous squamous cell carcinoma. Int J Biochem Cell Biol. 2015;65:182–191. doi:10.1016/j.biocel.2015.06.009.
   PubMed Web of Science ®Google Scholar
• Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol. 2018;78:237–247. doi:10.1016/j.jaad.2017.08.059.
   PubMed Web of Science ®Google Scholar
• Hombach S, Kretz M. Non-coding RNAs: classification, Biology and Functioning. Adv Exp Med Biol. 2016;937:3–17.
   PubMed Web of Science ®Google Scholar
• Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell. 2005;122:553–563. doi:10.1016/j.cell.2005.07.031.
   PubMed Web of Science ®Google Scholar
• Yadav L, Puri N, Rastogi V, Satpute P, Ahmad R, Kaur G. Matrix metalloproteinases and cancer - roles in threat and therapy. APJCP. 2014;15:1085–1091. doi:10.7314/APJCP.2014.15.3.1085.
   Google Scholar
• Huang C, Li Y, Guo Y, Zhang Z, Lian G, Chen Y, Li J, Su Y, Li J, Yang K, et al. MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells. Theranostics. 2018;8:3074–3086. doi:10.7150/thno.24281.
   PubMed Web of Science ®Google Scholar
• Wei W, Chen Y, Xu J, Zhou Y, Bai X, Yang M, Zhu J. Identification of Biomarker for Cutaneous Squamous Cell Carcinoma Using Microarray Data Analysis. J Cancer. 2018;9:400–406. doi:10.7150/jca.21381.
   PubMed Web of Science ®Google Scholar
• Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. 2013;3:1113–1121. doi:10.1158/2159-8290.CD-13-0202.
   PubMed Web of Science ®Google Scholar
• Ling Z, Liu D, Zhang G, Liang Q, Xiang P, Xu Y, Han C, Tao T. miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer. Oncol Rep. 2017;38:1621–1628. doi:10.3892/or.2017.5852.
   PubMed Web of Science ®Google Scholar
• Hou XW, Sun X, Yu Y, Zhao HM, Yang ZJ, Wang X, Cao XC. miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1. Neoplasma. 2017;64:526–534. doi:10.4149/neo_2017_406.
   PubMed Web of Science ®Google Scholar
• Cao ZG, Huang YN, Yao L, Liu YR, Hu X, Hou YF, Shao ZM. Positive expression of miR-361-5p indicates better prognosis for breast cancer patients. J Thorac Dis. 2016;8:1772–1779. doi:10.21037/jtd.2016.06.29.
   PubMed Web of Science ®Google Scholar
• Ma F, Zhang L, Ma L, Zhang Y, Zhang J, Guo B. MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1. J Exper Clin Cancer Res. 2017;36:158. doi:10.1186/s13046-017-0630-1.
   PubMed Web of Science ®Google Scholar
• Yu X, Li Z, Zheng H, Chan MT, Wu WK. NEAT1: a novel cancer-related long non-coding RNA. Cell Prolif. 2017;50(2):e12329.
   Web of Science ®Google Scholar
• Yu X, Liu X, Wang R, Wang L. Long non-coding RNA NEAT1 promotes the progression of hemangioma via the miR-361-5p/VEGFA pathway. Biochem Biophys Res Commun. 2019;512:825–831. doi:10.1016/j.bbrc.2019.03.084.
   PubMed Web of Science ®Google Scholar
• Holmberg C, Ghesquière B, Impens F, Gevaert K, Kumar JD, Cash N, Kandola S, Hegyi P, Wang TC, Dockray GJ, et al. Mapping proteolytic processing in the secretome of gastric cancer-associated myofibroblasts reveals activation of MMP-1, MMP-2, and MMP-3. J Proteome Res. 2013;12:3413–3422. doi:10.1021/pr400270q.
   PubMed Web of Science ®Google Scholar
• Tjomsland V, Pomianowska E, Aasrum M, Sandnes D, Verbeke CS, Gladhaug IP. Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: regulation by IL-1α and TGFβ and Implications for Migration of Pancreatic Cancer Cells. Neoplasia (New York, NY). 2016;18:447–456. doi:10.1016/j.neo.2016.06.003.
   PubMed Web of Science ®Google Scholar
• Chen Q, Cai J, Wang Q, Wang Y, Liu M, Yang J, Zhou J, Kang C, Li M, Jiang C. Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/beta-Catenin Pathway by Scaffolding EZH2. Clin Cancer Res. 2018;24:684–695. doi:10.1158/1078-0432.CCR-17-0605.
   PubMed Web of Science ®Google Scholar
• Kuasne H, Barros-Filho MC, Busso-Lopes A, Marchi FA, Pinheiro M, Munoz JJ, Scapulatempo-Neto C, Faria EF, Guimaraes GC, Lopes A, et al. Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact. Oncotarget. 2017;8:15294–15306. doi:10.18632/oncotarget.14783.
   PubMedGoogle Scholar
• Wang Y, Ding X, Liu B, Li M, Chang Y, Shen H, Xie SM, Xing L, Li Y. ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally. Mol Carcinog. 2020 Jan;59(1):73-86.
   Web of Science ®Google Scholar
• Chen Y, Peng S, Cen H, Lin Y, Huang C, Chen Y, Shan H, Su Y, Zeng L. MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer. Int J Oncol. 2019;55:142–156. doi:10.3892/ijo.2019.4803.
   PubMed Web of Science ®Google Scholar
• Kanitz A, Imig J, Dziunycz PJ, Primorac A, Galgano A, Hofbauer GF, Gerber AP, Detmar M. The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma. PloS One. 2012;7:e49568. doi:10.1371/journal.pone.0049568.
   PubMed Web of Science ®Google Scholar
• Gao F, Feng J, Yao H, Li Y, Xi J, Yang J. LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis. Artif Cells, Nanomed Biotechnol. 2019;47:776–782. doi:10.1080/21691401.2019.1577883.
   PubMed Web of Science ®Google Scholar
• Taiana E, Favasuli V, Ronchetti D, Todoerti K, Pelizzoni F, Manzoni M, Barbieri M, Fabris S, Silvestris I, Gallo Cantafio ME, et al. Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma. Leukemia. 2019;34:234–244. doi:10.1038/s41375-019-0542-5.
   PubMed Web of Science ®Google Scholar
• Li X, Zhou Y, Yang L, Ma Y, Peng X, Yang S, Li H, Liu J. LncRNA NEAT1 promotes autophagy via regulating miR-204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma. J Cell Physiol. 2020 Apr;235(4):3402-3413.
   Web of Science ®Google Scholar
• Zeng W, Lin Y, Lin H, Wu X. Silencing NEAT1 suppresses thyroid carcinoma via miR-126/NEAT1/VEGFA axis. Front Biosci (Landmark Edition). 2020;25:564–576. doi:10.2741/4821.
   PubMed Web of Science ®Google Scholar
• Ding F, Lai J, Gao Y, Wang G, Shang J, Zhang D, Zheng S. NEAT1/miR-23a-3p/KLF3: a novel regulatory axis in melanoma cancer progression. Cancer Cell Int. 2019;19:217. doi:10.1186/s12935-019-0927-6.
   PubMed Web of Science ®Google Scholar
• Ji Y, Wang M, Li X, Cui F. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/beta-Catenin Signaling. Yonsei Med J. 2019;60:336–345. doi:10.3349/ymj.2019.60.4.336.
   PubMed Web of Science ®Google Scholar
• Sun SJ, Lin Q, Ma JX, Shi WW, Yang B, Li F. Long non-coding RNA NEAT1 acts as oncogene in NSCLC by regulating the Wnt signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21:504–510.
   PubMed Web of Science ®Google Scholar